Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiation
Authors:
- 29 December 2004
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (2) , 497-502
Abstract
Granulocyte–macrophage colony-stimulating factor (GM-CSF) is a major regulator of monocyte to macrophage differentiation. In both humans and mice, the main phenotype of decreased GM-CSF function is pulmonary proteinosis due to aberrant function of alveolar macrophages. Recently, this cytokine has been shown to up-regulate a cyclic nucleotide phosphodiesterase, PDE1B. Two PDE1B variants with unique N-terminal sequences, PDE1B1 and PDE1B2, have been identified. Here, we report that the previously uncharacterized PDE1B2 is selectively increased by GM-CSF by stimulation of transcription at a previously unknown transcriptional start site. Analysis of the exon and intron organization of the PDE1B gene reveals that PDE1B2 has a different N-terminal sequence because of a separate first exon that is located 11.5 kb downstream from the PDE1B1 first exon. By using 5′-RACE, alignment of EST sequences, and a luciferase-reporter system, we provide evidence that PDE1B2 has a separate transcriptional start site from PDE1B1 that can be activated by monocyte differentiation. Furthermore, IL-4 treatment in the presence of GM-CSF, which shifts the differentiation from a macrophage to a dendritic cell phenotype, suppresses the up-regulation of PDE1B2. Induction of PDE1B2 is also found in T cells upon activation by PHA. Therefore, PDE1B2 may have a regulatory role in multiple immune cell types. Last, characterization of the catalytic properties of recombinant PDE1B2 shows that it prefers cGMP over cAMP as a substrate and, thus, is likely to regulate cGMP in macrophages. Also, PDE1B2 has a nearly 3-fold lower EC 50 for activation by calmodulin than PDE1B1.Keywords
This publication has 63 references indexed in Scilit:
- IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKLBlood, 2003
- Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)Journal of Biological Chemistry, 2002
- The alveolar macrophage as a model of calcium signaling in oxidative stressJournal of Toxicology and Environmental Health, Part B, 1998
- Identification, Quantitation, and Cellular Localization of PDE1 Calmodulin-Stimulated Cyclic Nucleotide PhosphodiesterasesMethods, 1998
- Identification and Characterisation of a Human Calmodulin-Stimulated Phosphodiesterase PDE1B1Cellular Signalling, 1997
- The role of cyclic nucleotides in neutrophil migrationGeneral Pharmacology: The Vascular System, 1996
- Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophagesClinical & Experimental Allergy, 1995
- A Novel Cyclic GMP Stimulated Phosphodiesterase from Rat BrainBiochemical and Biophysical Research Communications, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesteraseBiochemistry, 1991